PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, presenting promising developments across several health-related and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, extra trusted choice for therapeutic use, especially